Navigation Links
Metamark Genetics Board of Directors Appoints Shawn M. Marcell President and Chief Executive Officer
Date:4/30/2013

CAMBRIDGE, Mass., April 30, 2013 /PRNewswire/ -- Metamark Genetics, Inc., a leader in the discovery of novel molecular prognostic and diagnostic tests for cancer, today announced that industry veteran Shawn M. Marcell has been named the company's new president and chief executive officer. Mr. Marcell succeeds interim executive Michael Kauffman , M.D., who will remain on Metamark's board of directors. 

Metamark lead director Gregory C. Critchfield , M.D., said, "We are excited to welcome Shawn to Metamark as the company prepares to launch its first prognostic test, for prostate cancer. Shawn's broad and deep experience in life sciences, and his success in bringing innovative products to market, make him the ideal leader for Metamark as it grows into to a commercial organization."  Dr. Critchfield added, "We also would like to thank Michael Kauffman for his leadership during this important time in the company's evolution."

"Metamark's strategy to develop novel prognostic and diagnostic tests based on advanced quantitative histologic analysis has the potential to transform approaches to cancer and other major diseases," said Mr. Marcell. "I am thrilled to join the company and look forward to working with the entire team as we build a leading commercial stage molecular diagnostics company."

Mr. Marcell has nearly three decades of diverse executive, commercial and operational experience in life science and technology businesses. Most recently, he was the lead executive, serving as general manager of Hologic's (HOLX) wholly owned LIFECODES subsidiary, which was acquired by Immucor. He headed commercial operations at Sequenom (SQNM), which acquired SensiGen, where he served as president and CEO. Mr. Marcell has both CLIA laboratory and product launch experience and has had additional key management roles with Redpoint Bio, Prima Facie, Centocor and Abbott Diagnostics.

Mr. Marcell has been adjunct faculty and lecturer in Entrepreneurial Programs at the Wharton School and has served on numerous for-profit and non-profit boards.

About Metamark

Metamark Genetics is a privately held biotechnology company founded in 2007 to develop new function- based prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon and breast cancers. During 2013, Metamark plans to commercialize ProMarkTM – its lead prostate cancer prognostic test – through its Cambridge, MA CLIA-certified laboratory.  For more information, please visit the company's Website at www.metamarkgenetics.com.

MetamarkTM and ProMarkTM are trademarks of Metamark Genetics, Inc.

 

 

 


'/>"/>
SOURCE Metamark Genetics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Intermountain Healthcare and Myriad Genetics Enter Into Research Collaboration Agreement
2. Genelex Receives First Patent on Business Methods for Pharmacogenetics
3. Response Genetics, Inc. to Release Second Quarter Financial Results and Host Conference Call on August 14, 2012
4. Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets
5. Millennium Laboratories Announces Landmark Pharmacogenetics Clinical Outcomes Study
6. The International Serious Adverse Event Consortium and UC San Diego To Collaborate On Research Into The Genetics Of Drug Induced Renal Injury
7. Submit Questions to Nobel Laureates and Other Experts about Genetics and Society
8. Amgen to Acquire deCODE Genetics, a Global Leader in Human Genetics
9. Clinical Data from NewLink Genetics HyperAcute Prostate Cancer Immunotherapy Published in Journal of Immunotherapy
10. Epigenetics Technology Market (Epigenomics, DNA Methylation, Histone Modifications, RNA Interference, Cancer Therapeutics, Personalized Medicine) (2012 - 2017)
11. NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... FRANCISCO , January 24, 2017 ... a value of USD 3.8 billion by 2025, according ... The market growth can be attributed to the rising ... about early diagnosis of micro calcifications in breast tissue. ... Foundation, CDC, and Breast Cancer Organization are promoting the ...
(Date:1/24/2017)... Stock-Callers.com today has issued research reports on four ... Mallinckrodt PLC (NYSE: MNK ), Akorn Inc. (NASDAQ: ... DPLO ). According to pharmaceutical manufacturer PCI Synthesis, there ... Generic Drugs industry, including a possible reduction in FDA red ... a speedier FDA approval process that could reduce its backlog ...
(Date:1/24/2017)... 2017 Optoelectronic components have the capability ... interaction of these components with light makes them ... of applications. These components are primarily used in ... healthcare among others. Growing application across ... power consumption, reliability, scalability, and performance is fueling ...
Breaking Medicine Technology:
(Date:1/24/2017)... KS (PRWEB) , ... January 24, 2017 , ... ... Premensa, a leading natural supplement for relieving premenstrual syndrome, or PMS . ... at some point. These symptoms can include cramps, constipation, irritability, headaches, fatigue, and ...
(Date:1/24/2017)... ... ... Novel of Miracles”: a beautiful and poignant glimpse into the unexpected consequences of a ... Would Have Dreamed: A Novel of Miracles” is the creation of published author, Sharon Lee ... shares that she started her spiritual journey later in life, but mentions, “I have had ...
(Date:1/24/2017)... ... 2017 , ... “The Octagon of Spiritual Balances”: a guide for the ... creation of published author, Pastor Bernard J. Weathers, pastor of Word of Faith Ministries, ... religious education and a master degree in theology. , ““The Octagon of Spiritual Balances” ...
(Date:1/24/2017)... Raton, FL (PRWEB) , ... January 23, 2017 ... ... unique, highly refined coffee house-caliber protein and espresso drink, announced its CLICK® Coffee ... nutritional products. , CLICK® Coffee Protein Drink Mix has become popular among health-conscious ...
(Date:1/24/2017)... ... January 23, 2017 , ... United Nations Foundation ... of the Mexico City Policy, also known as the Global Gag Rule, last ... action, prohibits foreign non-governmental organizations from receiving any U.S. foreign assistance for family ...
Breaking Medicine News(10 mins):